Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

AOD-9604 vs HGH Fragment 176-191

Comparison

AOD-9604 and HGH Fragment 176-191 are two peptides people frequently compare. AOD-9604 is a peptide people use for fat loss and joint recovery. It mimics the fat-burning portion of growth hormone without the blood-sugar effects associated with GH itself. Not FDA-approved;… HGH Fragment 176-191 is a fragment of growth hormone that people use for fat loss, believed to retain the fat-burning properties of GH without affecting blood sugar. Evidence from animal studies is…

AOD-9604 HGH Fragment 176-191
What it is AOD-9604 is a peptide people use for fat loss and joint recovery. It mimics the fat-burning portion of growth hormone without the blood-sugar effects associated with GH itself. Not FDA-approved;… HGH Fragment 176-191 is a fragment of growth hormone that people use for fat loss, believed to retain the fat-burning properties of GH without affecting blood sugar. Evidence from animal studies is…
Primary uses
  • Obesity / adipose tissue reduction
  • Osteoarthritis / cartilage regeneration
  • Musculoskeletal injury recovery / orthopaedic applications
  • Metabolic / glycemic effects (blood glucose and insulin modulation)
  • Enhancement of anticancer drug delivery / oncology (in vitro, nanoparticle co-loading with doxorubicin)
  • Performance enhancement / body recomposition (GH-IGF-1 axis modulation)
How it works It mimics the fat-burning portion of growth hormone without the blood-sugar effects associated with GH itself. Not FDA-approved; banned by WADA; sold as a gray-market research compound. Evidence from animal studies is modest; human research is very limited. Not FDA-approved; gray-market research compound; regulatory status unverified.
Common dose 500 mcg, subcutaneous injection, once daily, fasted (morning) 500 mcg, subcutaneous injection, once daily, fasted (morning)
FDA status Not approved by US FDA; identified in confiscated vials in the USA and described as a non-approved compound operating in a 'gray market' (PMID: 41966639, PMID: 25208511) Not stated in reviewed literature — requires manual verification
Evidence level Mixed Human observational